The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

A stretch of viral DNA in the mouse genome gives cells in early-stage embryos the potential to become almost any cell type in ...

Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...

An international team including researchers from Nvidia and Microsoft has used AI on a biological trove of more than a ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

The AI model "Eden" is intended to generate new gene therapies for cancer and rare diseases, as well as active ingredients ...

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

Canada is wrestling with how gene-editing should translate to voluntary genetically modified food labels, or whether it even ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...